Related Experiment Videos

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and early-onset liver cirrhosis in two siblings

L Van Maldergem1, D Tuerlinckx, R J Wanders

  • 1Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Loverval, Belgium. vmald@skypro.be

Insights

Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency can cause early-onset liver cirrhosis and severe brain damage in infants. These serious complications may be underestimated in affected children.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency is a rare inherited metabolic disorder.
  • It affects fatty acid oxidation, leading to energy production deficits.
  • Early diagnosis and management are crucial for affected individuals.

Observation:

  • The study details two infant siblings diagnosed with LCHAD deficiency.
  • Clinical manifestations included liver enlargement, failure to thrive, and neurological impairment.
  • Infectious stress, such as rotavirus gastroenteritis, triggered severe episodes.

Findings:

  • Both patients presented with early-onset liver cirrhosis, a finding not commonly reported.
  • The second child experienced hepatic failure and status epilepticus, progressing to fatal heart failure.
  • Severe neurological disease, including coma and seizures, was observed.

Implications:

  • Liver cirrhosis and brain damage may be significant, yet underestimated, complications of LCHAD deficiency.
  • These severe outcomes can manifest early in infancy.
  • Increased awareness and monitoring for these complications are warranted in LCHAD deficiency cases.
Abstract

Related Concept Videos